Search
Results: 6
HPV - Immune response to infection and vaccination
M Stanley
Jun 16, 2011
Biotechnology Immunization Prevention Cancer Sexually Transmitted Infections Infectious Diseases Vaccine Related HPV and/or Cervical Cancer Vaccines HIV/AIDS 3 Prevention of disease and conditions and promotion of well-being 2 Aetiology 2.1 Biological and endogenous factors 3.4 Vaccines Inflammatory and immune system Infection 3 Good Health and Well Being
Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates.
Filippo Carboni, Annabel Kitowski, Charlotte Sorieul, Daniele Veggi, Marta C Marques, Davide Oldrini, Evita Balducci, Barbara Brogioni, Linda Del Bino, Alessio Corrado, Francesca Angiolini, Lucia Dello Iacono, Immaculada Margarit, Maria Rosaria Romano, Gonçalo JL Bernardes, Roberto Adamo
Apr 20, 2022
The introduction of glycoconjugate vaccines marks an important point in the fight against various infectious diseases. The covalent conjugation of relevant polysaccharide antigens to immunogenic carrier proteins enables the...
A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries.
Sebastián García Martí, Lisandro Colantonio, Ariel Bardach, Julieta Galante, Analía Lopez, Joaquín Caporale, Gerhart Knerer, Jorge Alberto Gomez, Federico Augustovski, Andrés Pichon-Riviere
Dec 14, 2020
BACKGROUND: A recently developed 10-valent pneumococcal non-typeable H influenzae protein D-conjugate vaccine (PHiD-CV) is expected to afford protection against more than two thirds of isolates causing IPD in children in Latin...
Different immune responses to three different vaccines following H6N1 low pathogenic avian influenza virus challenge in Taiwanese local chicken breeds.
Chi-Sheng Chang, Michèle Tixier-Boichard, Olympe Chazara, Yen-Pai Lee, Chih-Feng Chen, Poa-Chun Chang, Jan-Wei Chen, Bertrand Bed'hom
Jun 16, 2011
Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis
Schistosomiasis remains a neglected tropical disease of major public health concern with high levels of morbidity in various parts of the world. Although considerable efforts in implementing mass drug administration...
Ursula Panzner, Jean-Louis Excler, Jerome H Kim, Florian Marks, Darrick Carter, Afzal A Siddiqui
Sep 09, 2021
Rare Diseases Clinical Research Orphan Drug Biotechnology Immunization Vector-Borne Diseases Biodefense Emerging Infectious Diseases Vaccine Related Infectious Diseases Prevention Digestive Diseases 3 Prevention of disease and conditions and promotion of well-being 5.1 Pharmaceuticals 5 Development of treatments and therapeutic interventions 3.4 Vaccines Infection 3 Good Health and Well Being
Biopolymer‐based Carriers for DNA Vaccine Design
Abstract: Over the last 30 years, genetically engineered DNA has been tested as novel vaccination strategy against various diseases, including human immunodeficiency virus (HIV), hepatitis B, several parasites, and cancers....